Angioscope Device Market
Report ID: SQMIG35A4454
Report ID: SQMIG35A4454
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A4454 |
Region:
Global |
Published Date: August, 2026
Pages:
157
|Tables:
169
|Figures:
79
Global Angioscope Device Market size was valued at USD 310.00 Million in 2024 and is poised to grow from USD 334.18 Million in 2025 to USD 609.44 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).
Angioscope device market trends comprises optical instruments designed to visualize arterial interiors during endovascular procedures, offering clinicians imaging that reduces reliance on contrast agents and radiation. Its importance stems from the growing demand for minimally invasive cardiovascular therapies, which require navigation within vasculature. The primary driver of market expansion is the rising prevalence of peripheral artery disease and coronary artery disease among aging populations, prompting hospitals to adopt imaging tools. Over the past decade, adoption accelerated as manufacturers introduced fiber‑optic scopes and models, exemplified by Medtronic’s 2018 launch of the AngioVision system, which significantly improved procedural success rates and patient safety.
The second key factor shaping the global angioscope device market growth is the accelerating integration of digital health platforms that enable image analytics and remote collaboration, creating revenue streams for manufacturers and improving clinical outcomes. As hospitals invest in hybrid operating rooms equipped with high‑definition imaging and AI‑driven software, physicians can instantly share angioscopic footage with specialists worldwide, accelerating decision‑making in complex cases such as chronic total occlusions. This capability has sparked demand for interoperable devices with standardized data formats, prompting companies like Siemens Healthineers to develop cloud‑based repositories that reduce storage costs and facilitate patient monitoring, thereby expanding market size.
How is AI-driven Imaging Improving the Angioscope Device Market?
AI-driven imaging is improving the angioscope device market share by enabling faster image interpretation, enhanced visualization, and more consistent assessment of vascular conditions during minimally invasive procedures. AI algorithms can analyze high-resolution angioscopic images and video streams to identify abnormalities such as plaque, thrombus, calcification, and changes in vessel-wall characteristics, helping clinicians interpret complex vascular images more efficiently. Machine-learning models can also support image enhancement by reducing noise, improving contrast, and highlighting clinically relevant structures that may be difficult to distinguish during real-time procedures.
Integration of AI with digital imaging platforms can further facilitate automated image analysis, procedural documentation, and comparison of images collected at different stages of treatment. As hospitals increasingly adopt advanced cardiovascular imaging technologies, AI-enabled angioscopy can help improve workflow efficiency and provide clinicians with additional decision-support capabilities. These developments are encouraging manufacturers to invest in intelligent imaging platforms that combine angioscopic visualization with automated analytics, creating new opportunities for technology-driven growth in the angioscope device market.
Market snapshot - (2026-2033)
Global Market Size
USD 310.0 Million
Largest Segment
Flexible Angioscopes
Fastest Growth
Rigid Angioscopes
Growth Rate
7.8% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global angioscope device market is segmented by product type, application, end user, technology, usage and region. Based on product type, the market is segmented into flexible angioscopes and rigid angioscopes. Based on application, the market is segmented into peripheral vascular procedures, coronary procedures and others. Based on end user, the market is segmented into hospitals, specialty clinics and ambulatory surgical centers. Based on technology, the market is segmented into fiber optic and digital. Based on usage, the market is segmented into reusable and disposable. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Flexible angioscopes segment dominates because clinicians favor their ability to navigate tortuous vasculature, delivering superior imaging without compromising patient comfort. The inherent adaptability reduces procedure time and enhances therapeutic precision, prompting hospitals to prioritize flexible systems in procurement. Additionally, ongoing improvements in sheath design and miniaturization reinforce clinical confidence, cementing flexible devices as the preferred choice for a broad spectrum of vascular interventions across various clinical settings worldwide.
However, rigid angioscopes segment is witnessing the strongest growth momentum as interventional cardiologists adopt them for high‑resolution imaging in complex coronary lesions. Advances in ergonomics and material durability are expanding their use in structural heart procedures, driving increased demand and positioning rigid scopes as a burgeoning opportunity within the angioscope market.
Digital technology segment dominates because it provides real‑time high definition visualization, enabling precise navigation and immediate decision‑making during procedures. Integration with advanced software platforms facilitates image enhancement and data analytics, which appeals to tech‑savvy institutions seeking to improve outcomes. The seamless workflow and reduced reliance on external optics also lower maintenance burdens, prompting rapid adoption across a variety of procedural settings globally and across clinical disciplines.
Meanwhile, fiber optic technology segment is emerging as the key high‑growth area as manufacturers introduce ultra‑thin bundles that enhance flexibility and light transmission. This innovation revives interest in cost‑effective devices for peripheral procedures, encouraging broader adoption in clinics and ambulatory centers, thereby accelerating market expansion and diversifying application portfolios.
To get detailed segments analysis, Request a Free Sample Report
North America benefits from a mature healthcare infrastructure that supports rapid adoption of advanced endovascular technologies. The region’s strong research ecosystem fuels continuous innovation, while extensive reimbursement frameworks encourage widespread clinical use. Leading manufacturers maintain robust supply chains and regulatory expertise, ensuring timely market entry for new device generations. Collaboration between academic centers and industry accelerates product refinement and practitioner training. Furthermore, the presence of high‑volume cardiac centers creates a demand environment that sustains sustained production and investment, reinforcing North America’s position as a benchmark for clinical outcomes and product performance worldwide.
Angioscope device market outlook in United States reflects deep integration of cutting‑edge imaging solutions within cardiovascular programs. Clinical adoption is driven by strong physician advocacy and comprehensive payer coverage that underwrites procedure costs. The regulatory environment provides clear pathways for device approval, encouraging continual product evolution. Academic research centers contribute to evidence generation, supporting guideline endorsements that further embed angioscope technology into routine practice across diverse care settings.
Angioscope device market forecast in Canada is shaped by a publicly funded health system that emphasizes value‑based procurement and evidence‑driven adoption. Provincial health authorities prioritize technologies that demonstrate clinical benefit, fostering selective but impactful uptake. Collaborative networks between hospitals and manufacturers facilitate knowledge transfer and training, ensuring clinicians are proficient with advanced imaging modalities. The regulatory framework aligns closely with international standards, allowing seamless introduction of globally recognized angioscopy solutions into Canadian cardiac care pathways.
Europe’s expansion is propelled by a convergence of sophisticated clinical practices, supportive reimbursement policies, and strong commitment to medical device innovation. The region’s regulatory environment encourages harmonized product evaluation, enabling swift market access across multiple jurisdictions. Healthcare systems place high priority on improving procedural outcomes, prompting adoption of high‑resolution intravascular imaging. Collaborative research initiatives among leading European cardiovascular institutes generate robust clinical data that influence guideline updates. Together these factors create a fertile landscape for manufacturers to introduce next‑generation angioscopy platforms, positioning Europe as a dynamic hub for market growth and technological advancement.
Angioscope device market regional outlook in Germany benefits from a dense network of specialized cardiovascular centers that prioritize precision diagnostics. The country’s rigorous health technology assessment processes ensure that only clinically validated devices are reimbursed, fostering confidence among operators. Strong engineering expertise within the German medical device sector supports close partnerships with global manufacturers, facilitating tailored solutions for local clinical needs. Continuous education programs sponsored by professional societies reinforce practitioner proficiency with angioscopic techniques.
Angioscope device market regional forecast in United Kingdom exhibits rapid uptake driven by proactive health authorities that champion innovative cardiovascular care pathways. NHS procurement strategies encourage adoption of technologies that enhance procedural safety and reduce downstream costs. Academic hospitals serve as early adopters, generating real‑world evidence that informs national guidelines. Professional societies actively disseminate best‑practice recommendations, accelerating clinician familiarity and incorporation of angioscopy into routine interventional workflows.
Angioscope device market analysis in France is emerging as a focal point for novel imaging integration within cardiac programs. The French health system emphasizes cost‑effectiveness, prompting careful selection of technologies that demonstrate clear clinical advantage. Collaborative frameworks between research institutions and device firms foster pilot studies that assess angioscope performance in diverse patient cohorts. Growing interest from interventional cardiologists, coupled with supportive reimbursement mechanisms, is gradually expanding market presence across major metropolitan hospitals.
Asia Pacific is strengthening its position through a blend of expanding cardiovascular disease awareness, rising procedural volumes, and concerted investment in medical device capabilities. Countries in the region are establishing centers of excellence that prioritize cutting‑edge imaging to improve patient outcomes. Regulatory reforms streamline approval pathways, encouraging both domestic and multinational firms to introduce advanced angioscope systems. Educational initiatives and hands‑on training programs are enhancing clinician expertise, while growing patient demand for minimally invasive diagnostics drives steady market momentum across the Pacific basin.
Angioscope device market penetration in Japan is characterized by high clinical standards and early adoption of advanced imaging technologies. The country’s emphasis on meticulous procedural planning encourages integration of angioscopy for detailed vessel assessment. Collaborative research between university hospitals and industry accelerates generation of evidence supporting routine use. Reimbursement policies that recognize the value of precise diagnostics further incentivize clinicians to incorporate angioscopic tools into standard practice.
Angioscope device industry in South Korea reflects rapid modernization of interventional cardiology services. Government initiatives aimed at enhancing medical technology infrastructure have facilitated the introduction of sophisticated angioscope platforms. Leading hospitals prioritize training programs that equip interventionalists with the skills needed for high‑resolution intravascular imaging. Partnerships with global manufacturers enable localization of device technology, ensuring alignment with regional clinical preferences and regulatory requirements.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Minimally Invasive Demand
Adopting Robotic Assistance
High Capital Investment
Regulatory Approval Complexity
Request Free Customization of this report to help us to meet your business objectives.
The global angioscope device market is characterized by competition among established cardiovascular and medical-imaging companies, specialized intravascular imaging manufacturers, and emerging technology providers focused on improving real-time visualization and lesion assessment. Key players including Philips Healthcare, Boston Scientific, Abbott Laboratories, Terumo, Medtronic, Olympus, Conavi Medical, Infraredx, Cook Medical, Merit Medical Systems, Siemens Healthineers, and Karl Storz compete through imaging resolution, catheter deliverability, vessel visualization, multimodality integration, and software-assisted clinical decision-making. Competition is increasingly shifting toward intravascular imaging platforms that combine high-resolution visualization with artificial intelligence, automated lesion assessment, and physiological measurements.
Philips strengthened its position through its December 2025 agreement to acquire SpectraWAVE, adding the AI-supported HyperVue Enhanced Vascular Imaging system and X1-FFR technology to its existing intravascular imaging portfolio. Boston Scientific similarly offers the AVVIGO+ Multi-Modality Guidance System, integrating HD IVUS, automated lesion assessment, fast pullback, and FFR/DFR physiology in a single platform. Specialized companies such as Conavi Medical further intensify competition through hybrid intravascular imaging, with its Novasight Hybrid System combining IVUS and optical coherence tomography capabilities. These developments are encouraging manufacturers to pursue higher-resolution imaging, AI-enabled interpretation, streamlined catheter-lab workflows, and integrated imaging platforms to strengthen their positions in complex cardiovascular interventions.
Top Player’s Company Profile
Recent Developments in the Angioscope Device Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global angioscope device market is being propelled primarily by the expanding demand for minimally invasive cardiovascular procedures, which drives hospitals to adopt real‑time intravascular imaging for safer, quicker interventions. A second important catalyst is the rapid integration of digital health platforms that enable AI‑enhanced image analytics, remote collaboration and seamless data flow to electronic health records, further boosting adoption. North America remains the dominating region due to its mature infrastructure, strong reimbursement support and leading research centers, while flexible angioscopes are the prevailing segment because clinicians value their maneuverability in complex vasculature. However, high capital investment required for advanced systems acts as a notable restraint, slowing uptake in smaller facilities.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 310.0 Million |
| Market size value in 2033 | USD 609.44 Million |
| Growth Rate | 7.8% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Angioscope Device Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Angioscope Device Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Angioscope Device Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Angioscope Device Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Angioscope Device Market size was valued at USD 310.0 Million in 2024 and is poised to grow from USD 334.18 Million in 2025 to USD 609.44 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).
The global angioscope device market is shaped by intense competition among established medical imaging leaders and agile newcomers, driving rapid technology upgrades and strategic collaborations. Recent M&A activity, such as Siemens Healthineers’ acquisition of a niche intravascular imaging firm, and partnerships like Boston Scientific teaming with a AI‑analytics startup, illustrate how companies are leveraging complementary strengths to accelerate product innovation, expand geographic reach, and address emerging clinical demands for higher resolution and real‑time visualization. These moves intensify rivalry while fostering faster adoption of next‑generation angioscopic solutions. 'Philips Healthcare', 'Boston Scientific Corporation', 'Abbott Laboratories', 'Terumo Corporation', 'Asahi Intecc Co., Ltd.', 'Medtronic plc', 'Getinge AB', 'Richard Wolf GmbH', 'Karl Storz SE & Co. KG', 'Olympus Corporation', 'Conavi Medical Corp.', 'Infraredx, Inc.', 'Nipro Corporation', 'Cook Medical', 'Merit Medical Systems, Inc.', 'Becton, Dickinson and Company', 'GE HealthCare', 'Canon Medical Systems Corporation', 'Siemens Healthineers AG', 'Shimadzu Corporation'
The global shift toward minimally invasive cardiovascular interventions drives hospitals and clinics to seek technologies that enable precise vessel visualization while reducing patient trauma. Angioscope devices provide real‑time internal imaging, supporting clinicians in navigating complex anatomies with confidence. By offering enhanced procedural safety and shorter hospital stays, these systems align with the objectives of modern healthcare providers. Consequently, the increasing preference for less invasive treatment pathways directly fuels demand for angioscopic solutions across diverse clinical settings. This trend also encourages manufacturers to innovate and expand product portfolios.
Minimally Invasive Imaging Adoption: Healthcare providers are increasingly prioritizing minimally invasive diagnostics to reduce patient recovery time and procedural complications. This shift drives demand for angioscopes that combine high-resolution visualization with compact, ergonomic designs, enabling physicians to navigate delicate vascular structures more efficiently. Manufacturers are responding by introducing single-use and modular devices that streamline sterilization workflows while maintaining image fidelity. The growing preference for outpatient procedures further reinforces the need for portable angioscopic solutions that can be rapidly deployed across diverse clinical settings today.
Why does North America Dominate the Global Angioscope Device Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
